[Clinical tests of the therapeutic effect of a new difluocortolone valerate cream].
Diflucortolone valerate 0.1% in the form of a cream - Nerisona Cream - was investigated in various dermatological diseases. Very good results were achieved in 68.7% of the total of 64 treated cases, good results in 18.8%, moderate results in 9.4% and poor results in 3.1% of the cases. The patients assessed the cosmetic properties of Nerisona Cream as excellent. No side effects were observed.
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D002056:Burns / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003872:Dermatitis / Q000188:drug therapy; D004341:Drug Evaluation; D005260:Female; D005448:Fluocortolone / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008010:Lichen Planus / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009824:Ointments; D011244:Pregnadienediols / Q000627:therapeutic use*; D011565:Psoriasis / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*; D013543:Sweat Gland Diseases / Q000188:drug therapy; D014631:Valerates / Q000627:therapeutic use
D009824:Ointments; D011244:Pregnadienediols; D014631:Valerates; D005448:Fluocortolone
Klinische Prüfung zum Nachweis der therapeutischen Wirksamkeit einer neuen Creme mit Diflucortolonvalerianat